| CXHS2300090 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-09-27 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXHS2300089 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-09-27 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXHL2300992 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-09-13 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXHL2300991 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-09-13 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXHS2000036 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(1) | New Drug Application | 2020-09-30 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-09-30 | view |
| CXHS2000035 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(1) | New Drug Application | 2020-09-30 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-09-30 | view |
| CXHL2000391 | 脯氨酸恒格列净 | henagliflozin proline | Active ingredient | Chemical Drugs(1) | New Drug Application | 2020-08-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-19 | view |
| CXHL2000390 | 脯氨酸恒格列净 | henagliflozin proline | Active ingredient | Chemical Drugs(1) | New Drug Application | 2020-08-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-19 | view |
| CXHL2000389 | 脯氨酸恒格列净 | henagliflozin proline | Active ingredient | Chemical Drugs(1) | New Drug Application | 2020-08-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-19 | view |
| CXHL2000392 | 脯氨酸恒格列净 | henagliflozin proline | Active ingredient | Chemical Drugs(1) | New Drug Application | 2020-08-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-19 | view |
| CXHL2000232 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(1) | New Drug Application | 2020-05-29 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-05-28 | view |
| CXHB1700001 | 脯氨酸恒格列净 | henagliflozin proline | Active ingredient | Chemical Drugs | Supplementary Application | 2017-02-17 | 浙江天宇药业股份有限公司 | Zhejiang Tianyu Pharmaceutical Co Ltd | Certificate Issued | 2017-08-29 | view |
| CXHB1600062 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs | Supplementary Application | 2016-10-14 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2017-03-29 | view |
| CXHB1600063 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs | Supplementary Application | 2016-10-14 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2017-03-29 | view |
| CXHB1500002 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs | Supplementary Application | 2015-02-13 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2015-08-11 | view |
| CXHB1500001 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs | Supplementary Application | 2015-02-13 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2015-08-11 | view |
| CXHB1400084 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs | Supplementary Application | 2014-09-18 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2015-06-25 | view |
| CXHL1200076 | 脯氨酸恒格列净 | henagliflozin proline | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2012-04-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2013-04-11 | view |
| CXHL1200077 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(1.1) | New Drug Application | 2012-04-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2013-04-11 | view |
| CXHL1200080 | 脯氨酸恒格列净片 | henagliflozin proline | Tablet | Chemical Drugs(1.1) | New Drug Application | 2012-04-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2013-04-11 | view |
